Treatment of gingival defects with gingival mesenchymal stem cells derived from human fetal gingival tissue in a rat model

Abstract Background The study aimed to evaluate the efficacy and safety of gingival mesenchymal stem cells (GMSCs) from human fetal gingival tissue used for treating gingival defects in a rat model. Methods GMSCs were isolated from human fetal gingival tissue and identified by flow cytometry for nes...

Full description

Bibliographic Details
Main Authors: Jing Li, Shi-qing Xu, Kai Zhang, Wen-jian Zhang, Hong-lin Liu, Zhen Xu, Hong Li, Jin-ning Lou, Li-hong Ge, Bao-hua Xu
Format: Article
Language:English
Published: BMC 2018-02-01
Series:Stem Cell Research & Therapy
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13287-017-0751-7
id doaj-f13e94e63ac443bcb12b4e06fc90c9af
record_format Article
spelling doaj-f13e94e63ac443bcb12b4e06fc90c9af2020-11-24T21:21:42ZengBMCStem Cell Research & Therapy1757-65122018-02-01911810.1186/s13287-017-0751-7Treatment of gingival defects with gingival mesenchymal stem cells derived from human fetal gingival tissue in a rat modelJing Li0Shi-qing Xu1Kai Zhang2Wen-jian Zhang3Hong-lin Liu4Zhen Xu5Hong Li6Jin-ning Lou7Li-hong Ge8Bao-hua Xu9Dental Medical Center, China–Japan Friendship HospitalInstitute of Clinical Medical Sciences, China–Japan Friendship HospitalDental Medical Center, China–Japan Friendship HospitalInstitute of Clinical Medical Sciences, China–Japan Friendship HospitalInstitute of Clinical Medical Sciences, China–Japan Friendship HospitalDental Medical Center, China–Japan Friendship HospitalInstitute of Clinical Medical Sciences, China–Japan Friendship HospitalInstitute of Clinical Medical Sciences, China–Japan Friendship HospitalDepartment of Pediatric Dentistry, Peking University School and Hospital of StomatologyDental Medical Center, China–Japan Friendship HospitalAbstract Background The study aimed to evaluate the efficacy and safety of gingival mesenchymal stem cells (GMSCs) from human fetal gingival tissue used for treating gingival defects in a rat model. Methods GMSCs were isolated from human fetal gingival tissue and identified by flow cytometry for nestin, Oct4, vimentin, NANOG, CD105, and CD90. The immunogenicity of GMSCs was analyzed by mixed lymphocyte reactions; the tumorigenicity of GMSCs was evaluated by xenotransplanting into nude mice. The gingival defect animal model was established by mechanical resection in rats. GMSCs were transplanted into the defective area, and the regeneration of gingival tissue was observed twice weekly. Four weeks after transplantation, the gingival tissue was surgically cut down, and the graft was analyzed by immunohistochemistry staining for human mitochondrial antigens and rat CD3 and CD20. Results GMSCs from human fetal gingival tissue positively expressed nestin, Oct4, vimentin, NANOG, CD105, and CD90. There was no cell aggregation after mixed lymphocyte reactions, and interleukin-2 did not increase. Inoculation of GMSCs into nude mice for 6 months showed no tumor formation. GMSCs were transplanted into the gingiva defects of rats. One week after transplantation, the defect area was reduced, and after 3 weeks the morphology and color of local gingival tissue was similar to normal gingival tissue, and gingival height was the same as the normal control group. Conclusions Using GMSCs from human fetal gingival tissue to treat gingival defects is a safe and effective innovative treatment method.http://link.springer.com/article/10.1186/s13287-017-0751-7Gingival defectGingival mesenchymal stem cellsFetal stem cellsTransplantation
collection DOAJ
language English
format Article
sources DOAJ
author Jing Li
Shi-qing Xu
Kai Zhang
Wen-jian Zhang
Hong-lin Liu
Zhen Xu
Hong Li
Jin-ning Lou
Li-hong Ge
Bao-hua Xu
spellingShingle Jing Li
Shi-qing Xu
Kai Zhang
Wen-jian Zhang
Hong-lin Liu
Zhen Xu
Hong Li
Jin-ning Lou
Li-hong Ge
Bao-hua Xu
Treatment of gingival defects with gingival mesenchymal stem cells derived from human fetal gingival tissue in a rat model
Stem Cell Research & Therapy
Gingival defect
Gingival mesenchymal stem cells
Fetal stem cells
Transplantation
author_facet Jing Li
Shi-qing Xu
Kai Zhang
Wen-jian Zhang
Hong-lin Liu
Zhen Xu
Hong Li
Jin-ning Lou
Li-hong Ge
Bao-hua Xu
author_sort Jing Li
title Treatment of gingival defects with gingival mesenchymal stem cells derived from human fetal gingival tissue in a rat model
title_short Treatment of gingival defects with gingival mesenchymal stem cells derived from human fetal gingival tissue in a rat model
title_full Treatment of gingival defects with gingival mesenchymal stem cells derived from human fetal gingival tissue in a rat model
title_fullStr Treatment of gingival defects with gingival mesenchymal stem cells derived from human fetal gingival tissue in a rat model
title_full_unstemmed Treatment of gingival defects with gingival mesenchymal stem cells derived from human fetal gingival tissue in a rat model
title_sort treatment of gingival defects with gingival mesenchymal stem cells derived from human fetal gingival tissue in a rat model
publisher BMC
series Stem Cell Research & Therapy
issn 1757-6512
publishDate 2018-02-01
description Abstract Background The study aimed to evaluate the efficacy and safety of gingival mesenchymal stem cells (GMSCs) from human fetal gingival tissue used for treating gingival defects in a rat model. Methods GMSCs were isolated from human fetal gingival tissue and identified by flow cytometry for nestin, Oct4, vimentin, NANOG, CD105, and CD90. The immunogenicity of GMSCs was analyzed by mixed lymphocyte reactions; the tumorigenicity of GMSCs was evaluated by xenotransplanting into nude mice. The gingival defect animal model was established by mechanical resection in rats. GMSCs were transplanted into the defective area, and the regeneration of gingival tissue was observed twice weekly. Four weeks after transplantation, the gingival tissue was surgically cut down, and the graft was analyzed by immunohistochemistry staining for human mitochondrial antigens and rat CD3 and CD20. Results GMSCs from human fetal gingival tissue positively expressed nestin, Oct4, vimentin, NANOG, CD105, and CD90. There was no cell aggregation after mixed lymphocyte reactions, and interleukin-2 did not increase. Inoculation of GMSCs into nude mice for 6 months showed no tumor formation. GMSCs were transplanted into the gingiva defects of rats. One week after transplantation, the defect area was reduced, and after 3 weeks the morphology and color of local gingival tissue was similar to normal gingival tissue, and gingival height was the same as the normal control group. Conclusions Using GMSCs from human fetal gingival tissue to treat gingival defects is a safe and effective innovative treatment method.
topic Gingival defect
Gingival mesenchymal stem cells
Fetal stem cells
Transplantation
url http://link.springer.com/article/10.1186/s13287-017-0751-7
work_keys_str_mv AT jingli treatmentofgingivaldefectswithgingivalmesenchymalstemcellsderivedfromhumanfetalgingivaltissueinaratmodel
AT shiqingxu treatmentofgingivaldefectswithgingivalmesenchymalstemcellsderivedfromhumanfetalgingivaltissueinaratmodel
AT kaizhang treatmentofgingivaldefectswithgingivalmesenchymalstemcellsderivedfromhumanfetalgingivaltissueinaratmodel
AT wenjianzhang treatmentofgingivaldefectswithgingivalmesenchymalstemcellsderivedfromhumanfetalgingivaltissueinaratmodel
AT honglinliu treatmentofgingivaldefectswithgingivalmesenchymalstemcellsderivedfromhumanfetalgingivaltissueinaratmodel
AT zhenxu treatmentofgingivaldefectswithgingivalmesenchymalstemcellsderivedfromhumanfetalgingivaltissueinaratmodel
AT hongli treatmentofgingivaldefectswithgingivalmesenchymalstemcellsderivedfromhumanfetalgingivaltissueinaratmodel
AT jinninglou treatmentofgingivaldefectswithgingivalmesenchymalstemcellsderivedfromhumanfetalgingivaltissueinaratmodel
AT lihongge treatmentofgingivaldefectswithgingivalmesenchymalstemcellsderivedfromhumanfetalgingivaltissueinaratmodel
AT baohuaxu treatmentofgingivaldefectswithgingivalmesenchymalstemcellsderivedfromhumanfetalgingivaltissueinaratmodel
_version_ 1725998661726371840